Why Thirty Saliva Specimens Could Not Rank Two Cannabis Collection Devices

The thirty authentic saliva specimens in this method study were useful demonstrations of an assay, but they were not a matched comparison that could establish which collection device recovered more cannabinoid from the same people.

The two specimen groups had different exposure histories

Fifteen Quantisal specimens came from five chronic daily cannabis smokers participating in a controlled oral-THC protocol. Their histories included dronabinol dosing and smoking under that research program.

The fifteen Oral-Eze specimens came from three occasional cannabis smokers after a single smoked cannabis cigarette. Thus, collection device, participants, use frequency, route and sampling history differed together. Thirty specimens did not mean thirty independent participants.

A concentration difference has several possible explanations

If one group has higher THC or THCCOOH concentrations, the difference could reflect exposure and collection timing rather than device performance. These authentic specimens cannot isolate the device as the cause because the same participants were not sampled under matched conditions with both devices.

The separate fortified-sample validation experiments remain relevant to analytical performance in each buffer. Those experiments should be distinguished from comparisons between the two authentic-specimen groups.

The appropriate forensic use

The authentic-specimen application supports that the method could be applied to real human oral-fluid samples from those protocols. It does not establish a device conversion factor, a population detection rate or a dose–response relationship. A claimed device advantage requires a design that controls the biological and timing differences.

Related analysis: collection buffers and cannabinoid quantification.

Research cited

Concheiro, Lee, Lendoiro and Huestis (2013), Simultaneous Quantification of THC, THCCOOH, CBD and CBN in Oral Fluid by MicroFlow LC–High Resolution Mass Spectrometry. DOI: 10.1016/j.chroma.2013.04.071.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

The HGN Comparison Did Not Validate a Standalone Cannabis Impairment Test

The HGN analysis compared small groups defined by self-reported duration. It did not establish a standalone diagnostic accuracy for identifying cannabis-impaired drivers. What the statistical comparison involved Forty-four participants underwent horizontal gaze nystagmus assessment, with forty-three examined at three hours after smoking. The paper compared HGN incidence at that time…

Spread the love

Read Article: The HGN Comparison Did Not Validate a Standalone Cannabis Impairment Test

Stratified Cannabis Duration Patterns Coexisted With a Null Overall Correlation

The paper described an inverse pattern after grouping participants by self-reported duration, while its unstratified correlation between baseline blood THC and duration was nonsignificant. Both findings belong in an accurate account. The two analyses asked related questions differently Baseline blood measurements were available for sixty-four participants. The authors divided participants…

Spread the love

Read Article: Stratified Cannabis Duration Patterns Coexisted With a Null Overall Correlation

Percent-of-Maximum Cannabis Ratings Did Not Compare Absolute Severity

The paper’s average percent-of-maximum curve normalized each participant to that person’s own highest self-rating. Equal percentages on that graph did not necessarily mean equal absolute symptom severity across participants. The denominator was personal Wurz and DeGregorio summarized self-assessments from seventy-four participants after cannabis smoking. Each person’s ratings were expressed relative…

Spread the love

Read Article: Percent-of-Maximum Cannabis Ratings Did Not Compare Absolute Severity

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us